Living with chronic inflammatory demyelinating polyneuropathy (CIDP) means managing more than physical symptoms. Learn how to handle ‘relapse anxiety’ and differentiate between normal nerve sensations ...

If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn inhibitors and B-cell therapies may help.

Executives at Amgen (NASDAQ:AMGN) outlined several upcoming clinical milestones and recent data updates across its ...

Olympian Michael Klim forged his reputation on strength and athleticism. But after being blindsided by an incurable ...

Rare diseases affect only a small number of people yet have become an attractive target for ASX healthcare companies. ... Read More The post ASX healthcare players focusing on rare diseases as ...

Follow the latest headlines from ABC News, Australia's most trusted media source, with live events, audio and on-demand video from the national broadcaster.

IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the ...

A batch of untitled letters posted on the FDA’s database in recent days takes aim at what the agency has termed “false or misleading” drug ads from the likes of Novo Nordisk, argenx and Sobi. | A ...

Amgen’s fourth-quarter results reflected broad-based sales growth across its diverse portfolio, with management crediting strong volume gains in key products such as Repatha, Evenity, and Tezspire.

Michael Klim has revealed the stern warning he gave Michelle Owen when they first started dating because of his health. Read ...

Klim's proposal to Owen came six years after they began dating, marking a significant milestone in their relationship. The couple's romance was first made public in October 2019, just five months ...